Etiology and prognosis of highly elevated C-reactive protein levels (≥500 mg/L): A retrospective study about 168 measures in a series of 113 patients;Profil étiologique et pronostique des valeurs extrêmes (=500 mg/L) de protéine C-réactive étude rétrospective de 168 valeurs chez 113 patients

Revue de Medecine Interne

Volumn 32, Issue 11, 2011, Pages 663-668

  Hajek, V ^a   Pasquet, F ^a   Karkowski, L ^a   Lachenal, F ^a   Gerome P ^a   Pavic, M ^a  

^a HIA Desgenettes   (France)

Author keywords

C reactive protein; Infection; Inflammatory process; Prognosis

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL INFECTION; ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL DISCHARGE; HUMAN; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MORTALITY; MYCOSIS; NONHUMAN; PATHOGENESIS; PROGNOSIS; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD SPECIMEN COLLECTION; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNE TOLERANCE; INFECTION; LEUKOCYTOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; UP-REGULATION; YOUNG ADULT;

EID: 82455168001     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2011.04.001     Document Type: Article

References (36)

1. Tillett W.S., Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus. J Exp Med 1930, 52:561-571.
2. Macleod C.M., Avery O.T. The occurrence during acute infections of a protein not normally present in the blood: isolation and properties of the reactive protein. J Exp Med 1941, 73:183-190.
3. Clyne B., Olshaker J.S. The C-reactive protein. J Emerg Med 1999, 17:1019-1025.
4. Ballou S.P., Kushner I. C-reactive protein and the acute phase response. Adv Intern Med 1992, 37:313-336.
5. Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiology 1991, 183:133-145.
6. Gewurz H., Mold C., Siegel J., Fiedel B. C-reactive protein and the acute phase response. Adv Intern Med 1982, 27:345-372.
7. Palosuo T., Husman T., Koistinen J., Aho K. C-reactive protein in population samples. Acta Med Scand 1986, 220:175-179.
8. Pepys M.B. C-reactive protein fifty years on. Lancet 1981, 1:653-657.
9. Young B., Gleeson M., Cripps A.W. C-reactive protein: a critical review. Pathology 1991, 23:118-124.
10. Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941, 2:281-284.
11. Dripps R.D., Lamont A., Eckenhoff J.E. The role of anesthesia in surgical mortality. JAMA 1961, 178:261-266.
12. Vanderschueren S., Deeren D., Knockaert D.C., Bobbaers H., Bossuyt X., Peetermans W. Extremely elevated C-reactive protein. Eur J Intern Med 2006, 17:430-433.
13. Le Gall C. Significations d'une CRP supérieure à 500mg/L à propos de 91 prélèvements sanguins dans un centre hospitalier brestois sur 7ans [thèse] 2009, Université de Brest, Brest.
14. Benitz W.E., Han M.Y., Madan A., Ramachandra P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 1998, 102:E41.
15. Povoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., et al. Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care 2006, 10:63.
16. Castro-Guardiola A., Armengou-Arxe A., Viejo-Rodriguez A., Penarroja-Matutano G., Garcia-Bragado F. Differential diagnosis between community-acquired pneumonia and non-pneumonia diseases of the chest in the emergency ward. Eur J Intern Med 2000, 11:334-339.
17. Andersson R.E. Meta-analysis of the clinical and laboratory diagnosis of appendicitis. Br J Surg 2004, 91:28-37.
18. Gerdes L.U., Jorgensen P.E., Nexo E., Wang P. C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest 1998, 58:383-393.
19. Hjalmarsson C., Stenflo J., Borgstrom A. Activated protein C-protein C inhibitor complex, activation peptide of carboxypeptidase B and C-reactive protein as predictors of severe acute pancreatitis. Pancreatology 2009, 9:700-707.
20. Neoptolemos J.P., Kemppainen E.A., Mayer J.M., Fitzpatrick J.M., Raraty M.G., Slavin J., et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000, 355:1955-1960.
21. Robert J.H., Frossard J.L., Mermillod B., Soravia C., Mensi N., Roth M., et al. Early prediction of acute pancreatitis: prospective study comparing computed tomography scans, Ranson, Glascow, Acute Physiology and Chronic Health Evaluation II scores, and various serum markers. World J Surg 2002, 26:612-619.
22. Yadav D., Agarwal N., Pitchumoni C.S. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol 2002, 97:1309-1318.
23. Ozguroglu M, Bolayirli M, Orhanoglu T, et al. Acute phase proteins in malignancy: role of CRP in the discrimination of infectious complications in cancer patients. Eur J Cancer Suppl 2005;3(2):70.
24. Muntoni S., Atzori L., Mereu R., Satta G., Macis M.D., Congia M., et al. Serum lipoproteins and cancer. Nutr Metab Cardiovasc Dis 2009, 19:218-225.
25. Penel N., Fournier C., Degardin M., Kouto H., N'Guyen M. Fièvre et tumeur solide valeur diagnostique de la procalcitonine et de la protéine C-réactive. Rev Med Interne 2001, 22:706-714.
26. Kallio R., Surcel H.M., Bloigu A., Syrjala H. C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 2000, 36:889-894.
27. Kompoti M., Drimis S., Papadaki A., Kotsomytis K., Poulopoulou C., Gianneli D., et al. Serum C-reactive protein at admission predicts in-hospital mortality in medical patients. Eur J Intern Med 2008, 19:261-265.
28. Hogarth M.B., Gallimore R., Savage P., Palmer A.J., Starr J.M., Bulpitt C.J., et al. Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient. Age Ageing 1997, 26:153-158.
29. Lee C.C., Chen S.Y., Tsai C.L., Wu S.C., Chiang W.C., Wang J.L., et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 2008, 29:322-327.
30. Lobo S.M., Lobo F.R., Bota D.P., Lopes-Ferreira F., Soliman H.M., Melot C., et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123:2043-2049.
31. Gil H., Méaux-Ruault N., Magy N., Hafsaoui C., Bernard D., Dupond J.L. Valeur pronostique du dosage de la protéine C réactive (CRP) dans les pneumopathies aiguës infectieuses du sujet âgé corrélation avec le score de Fine 97. Rev Med Interne 2007, 28:213-217.
32. Chalmers J.D., Singanayagam A., Hill A.T. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008, 121:219-225.
33. Claeys R., Vinken S., Spapen H., ver Elst K., Decochez K., Huyghens L., et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002, 30:757-762.
34. Coelho L., Povoa P., Almeida E., Fernandes A., Mealha R., Moreira P., et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care 2007, 11:92.
35. Reny J.L., Vuagnat A., Ract C., Benoit M.O., Safar M., Fagon J.Y. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002, 30:529-535.
36. Roger P.M., Hung S., de Salvador F., Allieri-Rosenthal A., Farhad R., Pulcini C., et al. Utilité de la protéine C-réactive dans le suivi thérapeutique des patients infectés. Med Mal Infect 2009, 39:319-324.